Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Intellia Therapeutics, Inc., a biopharmaceutical company based in Cambridge, Massachusetts, announced their business updates and financial results for the second quarter ending on June 30, 2026. Known for their focus on revolutionizing medicine through CRISPR gene editing and other core technologies, Intellia Therapeutics, Inc. (Nasdaq: NTLA) shared their latest information.